melatonin has been researched along with Endometrial Neoplasms in 17 studies
Endometrial Neoplasms: Tumors or cancer of ENDOMETRIUM, the mucous lining of the UTERUS. These neoplasms can be benign or malignant. Their classification and grading are based on the various cell types and the percent of undifferentiated cells.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Laboratory study was via cultured endometrial cancer cells." | 5.72 | Melatonin Inhibits 17β-Estradiol-Induced Epithelial-Mesenchymal Transition in Endometrial Adenocarcinoma Cells via Upregulating Numb Expression. ( Li, C; Li, M; Liu, Z; Qi, S; Zhang, H; Zhao, X, 2022) |
| "Melatonin is a hormone synthesized in the pineal and extra-pineal organs such as the digestive tract, bone marrow, retina and more." | 2.66 | Molecular and Biological Functions of Melatonin in Endometrial Cancer. ( Asemi, Z; Chaichian, S; Chamani, M; Dana, PM; Moazzami, B; Mobini, M; Sadoughi, F; Shafabakhsh, R, 2020) |
| "Of particular relevance to breast cancer risk, melatonin may also block the estrogen receptor ERalpha and impact the enzyme aromatase, which produces estradiol." | 2.45 | Circulating melatonin and the risk of breast and endometrial cancer in women. ( Schernhammer, ES; Viswanathan, AN, 2009) |
| "Laboratory study was via cultured endometrial cancer cells." | 1.72 | Melatonin Inhibits 17β-Estradiol-Induced Epithelial-Mesenchymal Transition in Endometrial Adenocarcinoma Cells via Upregulating Numb Expression. ( Li, C; Li, M; Liu, Z; Qi, S; Zhang, H; Zhao, X, 2022) |
| "Treatment with melatonin restricted estrogen/UBC/SDHB-induced succinate accumulation and upregulated expression of KCNQ1 and reduced the succinate-mediated growth of UECC in vitro and in vivo." | 1.56 | Melatonin alleviates progression of uterine endometrial cancer by suppressing estrogen/ubiquitin C/SDHB-mediated succinate accumulation. ( Chang, K; Chang, R; Gu, C; Li, M; Qiu, X; Qu, Y; Wang, J; Wang, Y; Xie, F; Yang, H; Ye, J; Zhang, B, 2020) |
| "With low-grade endometrial carcinomas, the average index of EGF blood plasma level is higher compared to that of the patients with high-grade endometrial adenocarcinomas." | 1.40 | [Expression of epidermal growth factor receptor and concentrations of epidermal growth factor and melatonin in endometrial carcinoma]. ( Dznelashvili, N; Kasradze, D; Tavartkiladze, A, 2014) |
| "Using data from the Australian National Endometrial Cancer Study, a population-based case-control study of 1399 cases and 1539 controls, we examined the association between season of birth and risk of endometrial cancer." | 1.37 | Season of birth and risk of endometrial cancer. ( Nagle, CM; Rowlands, IJ; Spurdle, AB; Webb, PM; Weinstein, P, 2011) |
| "Melatonin has several oncostatic properties, including possible anti-estrogenic and anti-aromatase activity, and seems to be linked with fat metabolism." | 1.34 | Night shift work and the risk of endometrial cancer. ( Hankinson, SE; Schernhammer, ES; Viswanathan, AN, 2007) |
| "After surgical ablation of the breast tumors, serum's ability to increase MCF-7 cell proliferation decreased significantly." | 1.31 | Influence of serum from healthy or breast tumor-bearing women on the growth of MCF-7 human breast cancer cells. ( Alvarez, A; Bartsch, C; Bartsch, H; Cos, S; Mediavilla, MD; Sanchez-Barcelo, EJ, 2000) |
| "Pretreatment with luzindole, which is a selective melatonin receptor antagonist, prior to the addition of melatonin also blocked the inhibitory effect of melatonin on Ishikawa cells." | 1.31 | Differential growth inhibitory effect of melatonin on two endometrial cancer cell lines. ( Ishizuka, B; Kanishi, Y; Kobayashi, Y; Noda, S; Saito, K, 2000) |
| "68 women were diagnosed with endometrial cancer, 70 patients had abnormal bleeding." | 1.30 | A significant correlation between melatonin deficiency and endometrial cancer. ( Grin, W; Grünberger, W, 1998) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (17.65) | 18.2507 |
| 2000's | 8 (47.06) | 29.6817 |
| 2010's | 3 (17.65) | 24.3611 |
| 2020's | 3 (17.65) | 2.80 |
| Authors | Studies |
|---|---|
| Zhang, H | 1 |
| Qi, S | 1 |
| Liu, Z | 1 |
| Li, C | 1 |
| Li, M | 2 |
| Zhao, X | 1 |
| Dana, PM | 1 |
| Sadoughi, F | 1 |
| Mobini, M | 1 |
| Shafabakhsh, R | 1 |
| Chaichian, S | 1 |
| Moazzami, B | 1 |
| Chamani, M | 1 |
| Asemi, Z | 1 |
| Gu, C | 1 |
| Yang, H | 1 |
| Chang, K | 1 |
| Zhang, B | 1 |
| Xie, F | 1 |
| Ye, J | 1 |
| Chang, R | 1 |
| Qiu, X | 1 |
| Wang, Y | 1 |
| Qu, Y | 1 |
| Wang, J | 1 |
| de Almeida Chuffa, LG | 1 |
| Seiva, FRF | 1 |
| Cucielo, MS | 1 |
| Silveira, HS | 1 |
| Reiter, RJ | 2 |
| Lupi, LA | 1 |
| Dznelashvili, N | 1 |
| Kasradze, D | 1 |
| Tavartkiladze, A | 1 |
| Watanabe, M | 1 |
| Kobayashi, Y | 3 |
| Takahashi, N | 1 |
| Kiguchi, K | 2 |
| Ishizuka, B | 3 |
| Viswanathan, AN | 2 |
| Schernhammer, ES | 2 |
| Rowlands, IJ | 1 |
| Weinstein, P | 1 |
| Nagle, CM | 1 |
| Spurdle, AB | 1 |
| Webb, PM | 1 |
| Itoh, MT | 1 |
| Kondo, H | 1 |
| Okuma, Y | 1 |
| Sato, S | 1 |
| Kanishi, Y | 2 |
| Hamada, N | 1 |
| Hankinson, SE | 1 |
| Erren, TC | 1 |
| Pape, HG | 1 |
| Piekarski, C | 1 |
| Cohen, M | 1 |
| Small, RA | 1 |
| Brzezinski, A | 1 |
| Grin, W | 1 |
| Grünberger, W | 1 |
| Chubb, CR | 1 |
| Cos, S | 1 |
| Alvarez, A | 1 |
| Mediavilla, MD | 1 |
| Bartsch, C | 2 |
| Bartsch, H | 2 |
| Sanchez-Barcelo, EJ | 1 |
| Noda, S | 1 |
| Saito, K | 1 |
| Deerberg, F | 1 |
| Mecke, D | 1 |
3 reviews available for melatonin and Endometrial Neoplasms
| Article | Year |
|---|---|
Molecular and Biological Functions of Melatonin in Endometrial Cancer.
Topics: Animals; Antineoplastic Agents; Apoptosis; Endometrial Neoplasms; Female; Humans; Melatonin; Oxidati | 2020 |
Mitochondrial functions and melatonin: a tour of the reproductive cancers.
Topics: Animals; Breast Neoplasms; Endometrial Neoplasms; Female; Genital Neoplasms, Female; Humans; Male; M | 2019 |
Circulating melatonin and the risk of breast and endometrial cancer in women.
Topics: Aromatase; Breast Neoplasms; Carcinoma; Case-Control Studies; Cell Transformation, Neoplastic; Circa | 2009 |
14 other studies available for melatonin and Endometrial Neoplasms
| Article | Year |
|---|---|
Melatonin Inhibits 17β-Estradiol-Induced Epithelial-Mesenchymal Transition in Endometrial Adenocarcinoma Cells via Upregulating Numb Expression.
Topics: Adenocarcinoma; Cell Line, Tumor; Cell Proliferation; Endometrial Neoplasms; Epithelial-Mesenchymal | 2022 |
Melatonin alleviates progression of uterine endometrial cancer by suppressing estrogen/ubiquitin C/SDHB-mediated succinate accumulation.
Topics: Animals; Apoptosis; Biomarkers, Tumor; Cell Proliferation; Endometrial Neoplasms; Estrogens; Female; | 2020 |
[Expression of epidermal growth factor receptor and concentrations of epidermal growth factor and melatonin in endometrial carcinoma].
Topics: Adult; Aged; Endometrial Neoplasms; Enzyme-Linked Immunosorbent Assay; Epidermal Growth Factor; ErbB | 2014 |
Expression of melatonin receptor (MT1) and interaction between melatonin and estrogen in endometrial cancer cell line.
Topics: Cell Line, Tumor; Endometrial Neoplasms; Estrogens; Female; Humans; Melatonin; Receptor, Melatonin, | 2008 |
Season of birth and risk of endometrial cancer.
Topics: Australia; Case-Control Studies; Endometrial Neoplasms; Female; Humans; Melatonin; Parturition; Risk | 2011 |
Melatonin binding sites in estrogen receptor-positive cells derived from human endometrial cancer.
Topics: Binding Sites; Endometrial Neoplasms; Endometrium; Female; Humans; Melatonin; Receptors, Estrogen; R | 2003 |
Night shift work and the risk of endometrial cancer.
Topics: Adult; Body Mass Index; Cohort Studies; Endometrial Neoplasms; Female; Humans; Melatonin; Middle Age | 2007 |
Not all shifts are equal: it's time for comprehensive exposure metrics in chronodisruption research.
Topics: Data Interpretation, Statistical; Endometrial Neoplasms; Female; Humans; Male; Melatonin; Prospectiv | 2008 |
Hypotheses: melatonin/steroid combination contraceptives will prevent breast cancer.
Topics: Breast Neoplasms; Contraceptives, Oral, Combined; Endometrial Neoplasms; Female; Humans; Melatonin; | 1995 |
A significant correlation between melatonin deficiency and endometrial cancer.
Topics: Aging; Austria; Biomarkers, Tumor; Cohort Studies; Endometrial Neoplasms; Female; Humans; Incidence; | 1998 |
Re: a significant correlation between melatonin deficiency and endometrial cancer.
Topics: Endometrial Neoplasms; Female; Humans; Melatonin | 1999 |
Influence of serum from healthy or breast tumor-bearing women on the growth of MCF-7 human breast cancer cells.
Topics: Adenocarcinoma, Papillary; Breast Neoplasms; Cell Division; Culture Media; Endometrial Neoplasms; Es | 2000 |
Differential growth inhibitory effect of melatonin on two endometrial cancer cell lines.
Topics: Adenocarcinoma; Antineoplastic Agents; Cell Count; Cell Division; Endometrial Neoplasms; Estradiol; | 2000 |
Seasonal rhythms of 6-sulphatoxymelatonin (aMT6s) excretion in female rats are abolished by growth of malignant tumors.
Topics: Animals; Endometrial Neoplasms; Female; Mammary Neoplasms, Experimental; Melatonin; Neoplasms, Exper | 2001 |